http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1912301_PMID35696646

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103168388_AID1912301_PMID35696646_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440200558_AID1912301_PMID35696646_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID1912301_PMID35696646_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242256089_AID1912301_PMID35696646_VALUE3
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Therapeutic window, ratio of IC50 for cytotoxicity against human PC-3M cells expressing PTB/GFP fusion protein assessed as reduction in ATP level to IC50 for anticancer activity in human PC-3M cells expressing PTB/GFP fusion protein assessed as reduction of perinucleolar compartment
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242256089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103168388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440200558
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1912301

Total number of triples: 12.